296 top medical experts on Mucopolysaccharidoses across 48 countries and 19 U.S. states, including 118 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Mucopolysaccharidoses: Group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inborn Errors Carbohydrate Metabolism (1,325), Lysosomal Storage Diseases (2,636), Mucinoses (506) and Narrower Categories: Mucopolysaccharidosis I (1,883), Mucopolysaccharidosis II (1,613), Mucopolysaccharidosis III (1,142), Mucopolysaccharidosis IV (1,007), Mucopolysaccharidosis VI (780), Mucopolysaccharidosis VII (367).
  4. Clinical Trials ClinicalTrials.gov : at least 155 including 15 Active, 70 Completed, 29 Recruiting


  

        

                    


    Computing Expert Listing ...

);